Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1.52 Million - $1.78 Million
-60,000 Reduced 15.79%
320,000 $8.95 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.29 Million - $1.48 Million
-49,900 Reduced 11.61%
380,000 $10.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.13 Million - $1.46 Million
43,100 Added 11.14%
429,900 $12.4 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $2.39 Million - $2.79 Million
74,400 Added 23.82%
386,800 $12.8 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $5.67 Million - $6.56 Million
156,900 Added 100.9%
312,400 $11.5 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $4.16 Million - $5.41 Million
105,500 Added 211.0%
155,500 $6.34 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $4,175 - $5,450
100 Added 0.2%
50,000 $2.56 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $870,824 - $1.06 Million
19,900 Added 66.33%
49,900 $2.18 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $1.37 Million - $1.7 Million
-30,000 Reduced 50.0%
30,000 $1.55 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $1.86 Million - $2.76 Million
-45,000 Reduced 42.86%
60,000 $3.54 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $1.75 Million - $2.25 Million
-44,600 Reduced 29.81%
105,000 $4.52 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $3.3 Million - $3.72 Million
98,600 Added 193.33%
149,600 $5.42 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $33,470 - $42,560
1,000 Added 2.0%
51,000 $1.88 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $317,500 - $372,500
-10,000 Reduced 16.67%
50,000 $1.84 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $903,600 - $1.1 Million
30,000 Added 100.0%
60,000 $1.96 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $810,900 - $1.16 Million
30,000 New
30,000 $979,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Continental Advisors LLC Portfolio

Follow Continental Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.